Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES
476 words·~2 min read·
/register/2002/02/13/02-3429A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. *Name of Committee: * Recombinant DNA Advisory Committee. *Date: * March 7-8, 2002. *Time: * 8 a.m. to 5 p.m. *Agenda: * RAC will review and discuss: selected human gene transfer protocols; data management activities related to human gene transfer clinical trials; informed consent issues;
Liver-Directed Gene Transfer of rAAV for Hemophilia B; Update of Clinical Protocol and Data. The RAC meeting will be Web cast and can be viewed at *http://www.webconferences.com/nihoba* during the meeting. *Place: * Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. *Contact Person: * Laurie Harris, RAC Program Assistant, Office of Biotechnology Activities, Rockledge 1, Room 750, Bethesda, MD 20892, 301-496-9839. Information is also available on the Institute's/Center's home page: *www4.od.nih.gov/oba/,* where an agenda and any additional Information for the meeting will be posted when available.
OMB's “Mandatory Information Requirements for Federal Assistance Program Announcements” (45 FR 39592, June 11, 1980) requires a statement concerning the official government programs contained in the Catalog of Federal Domestic Assistance. Normally NIH lists in its announcements the number and title of affected individual programs for the guidance of the public. Because the guidance in this notice covers virtually every NIH and Federal research program in which DNA recombinant molecule techniques could be used, it has been determined not to be cost effective or in the public interest to attempt to list these programs.
Such a list would likely require several additional pages. In addition, NIH could not be certain that every Federal program would be included as many Federal agencies, as well as private organizations, both national and international, have elected to follow the NIH Guidelines. In lieu of the individual program listing, NIH invites readers to direct questions tot he information address above about whether individual programs listed in the Catalog of Federal Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program, National Institutes of Health, HHS) Dated:
February 5, 2002. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 02-3429 Filed 2-12-02; 8:45 am]